|
|
HIV/AIDS Podcast Central: Home
Welcome to TheBody.com's HIV/AIDS Podcast Central! Here is an archive of dozens of audio interviews with people with HIV, doctors, researchers and others. You can easily listen to any of these interviews online or transfer them to your MP3 player; subscribe to our podcast series with iTunes or an RSS reader. You can also read any of our podcast transcripts. If you need help, click here for our frequently asked questions. If you'd like to get started listening, two of our favorite podcasts are available below, and there are plenty more accessible by topic to the left.
To learn more about subscribing to Podcast Central, click here.
If you're using a podcast subscription program, copy and paste the following URL:
If you'd like to get e-mail notifications when a new podcast is posted, enter your name below:
If you have no idea what we're talking about, but would like to learn how to subscribe to a podcast, download a podcast subscription program like iTunes or Juice and follow the program's instructions. (iTunes' instructions are here; Juice's are here.)
An author named Guy Hart-Davis also wrote a book that provides instructions on how to load podcasts onto your iPod or iPod Mini using Windows or a Mac.
|
This Month in HIV Featured Podcast: A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy) |
| |
|
An Interview With Daniel Berger, M.D.
On Nov. 10, Egrifta (tesamorelin) became the first drug approved in the U.S. to treat unusual fat gain, or lipohypertrophy, in people with HIV. In our latest episode of This Month in HIV, we talk with noted HIV researcher Daniel Berger, M.D., about how Egrifta works, who should take it, and what else we know to date about the treatment of lipohypertrophy.
You can also see more This Month in HIV podcasts, subscribe to this series in iTunes or get e-mail notifications for new This Month in HIV podcasts.
|
|
Advertisement
|
Copyright © 2007-2011 The HealthCentral Network, Inc. All rights reserved. Podcast disclaimer
|